학술논문
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Document Type
Article
Author
Gianni, Luca; Pienkowski, Tadeusz; Im, Young-Hyuck; Roman, Laslo; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Staroslawska, Elżbieta; de la Haba-Rodriguez, Juan; Im, Seock-Ah; Pedrini, Jose Luiz; Poirier, Brigitte; Morandi, Paolo; Semiglazov, Vladimir; Srimuninnimit, Vichien; Bianchi, Giulia; Szado, Tania; Ratnayake, Jayantha; Ross, Graham; Valagussa, Pinuccia
Source
In Lancet Oncology 2012 13(1):25-32
Subject
Language
ISSN
1470-2045